Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Baxter
Boehringer Ingelheim
Medtronic
McKinsey

Last Updated: June 28, 2022

CLINICAL TRIALS PROFILE FOR SOLRIAMFETOL HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Solriamfetol Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02806895 ↗ Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA Completed Jazz Pharmaceuticals Phase 2 2016-07-05 This trial is a randomized, double-blind, placebo-controlled, crossover study to evaluate the effect of JZP-110 on driving performance in subjects with excessive sleepiness due to obstructive sleep apnea.
NCT02806908 ↗ Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy Completed Jazz Pharmaceuticals Phase 2 2016-06-01 This trial is a randomized, double-blind, placebo-controlled, crossover study to evaluate the effect of JZP-110 on driving performance in subjects with excessive sleepiness due to narcolepsy.
NCT03868943 ↗ Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma Recruiting National Cancer Institute (NCI) Phase 2 2021-01-27 This phase II trial studies the side effects of solriamfetol in improving sleep in patients with grade II-IV glioma. Solriamfetol is a wakefulness-promoting drug. Giving solriamfetol may improve sleep, memory, fatigue, mood, or quality of life in patients with brain tumors (gliomas).
NCT03868943 ↗ Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma Recruiting Wake Forest University Health Sciences Phase 2 2021-01-27 This phase II trial studies the side effects of solriamfetol in improving sleep in patients with grade II-IV glioma. Solriamfetol is a wakefulness-promoting drug. Giving solriamfetol may improve sleep, memory, fatigue, mood, or quality of life in patients with brain tumors (gliomas).
NCT04602936 ↗ Solriamfetol in Binge Eating Disorder Not yet recruiting Jazz Pharmaceuticals Phase 4 2020-11-15 The goal of this project is to evaluate the efficacy and tolerability of the novel dopamine and norepinephrine reuptake inhibitor (DNRI) solriamfetol in the treatment of binge eating disorder (BED).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Solriamfetol Hydrochloride

Condition Name

Condition Name for Solriamfetol Hydrochloride
Intervention Trials
Excessive Sleepiness 4
Obstructive Sleep Apnea 3
Excessive Daytime Somnolence 2
Narcolepsy 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Solriamfetol Hydrochloride
Intervention Trials
Disorders of Excessive Somnolence 5
Sleepiness 5
Sleep Apnea, Obstructive 3
Sleep Apnea Syndromes 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Solriamfetol Hydrochloride

Trials by Country

Trials by Country for Solriamfetol Hydrochloride
Location Trials
United States 15
Italy 2
Netherlands 2
Spain 1
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Solriamfetol Hydrochloride
Location Trials
North Carolina 3
Massachusetts 2
Washington 1
Texas 1
South Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Solriamfetol Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Solriamfetol Hydrochloride
Clinical Trial Phase Trials
Phase 4 5
Phase 2/Phase 3 1
Phase 2 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Solriamfetol Hydrochloride
Clinical Trial Phase Trials
Recruiting 4
Not yet recruiting 3
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Solriamfetol Hydrochloride

Sponsor Name

Sponsor Name for Solriamfetol Hydrochloride
Sponsor Trials
Jazz Pharmaceuticals 6
National Cancer Institute (NCI) 1
Wake Forest University Health Sciences 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Solriamfetol Hydrochloride
Sponsor Trials
Industry 6
Other 5
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
McKesson
Harvard Business School
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.